Korro Bio (KRRO) Non Operating Interest Expenses (2018 - 2023)

Korro Bio (KRRO) has reported Non Operating Interest Expenses for 4 consecutive years, with $284000.0 the latest figure, recorded in Q1 2023.

• For the quarter ending Q1 2023, Non Operating Interest Expenses rose 59.55% year-over-year to $284000.0; the trailing twelve-month figure through Sep 2023 stood at $596000.0 (down 28.28% YoY), and the FY2022 full-year result was $961000.0, up 25.79% from the prior year.
• Non Operating Interest Expenses slipped to $284000.0 in Q1 2023 per KRRO's latest filing, from $312000.0 in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $312000.0 in Q4 2022 and bottomed at $178000.0 in Q1 2022.
• Historically, Non Operating Interest Expenses has averaged $223222.2 across 3 years, with a median of $208000.0 in 2022.
• The widest YoY moves for Non Operating Interest Expenses: up 71.43% in 2022, down 18.35% in 2022.
• Over 3 years, Non Operating Interest Expenses stood at $182000.0 in 2021, then surged by 71.43% to $312000.0 in 2022, then declined by 8.97% to $284000.0 in 2023.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $284000.0, $312000.0, and $263000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.